Human papillomaviruses; Epithelial tropisms, and the development of neoplasia

Viruses

Volumn 7, Issue 7, 2015, Pages 3863-3890

  Egawa, Nagayasu ^a,b   Egawa, Kiyofumi ^c,d   Griffin, Heather ^a,b   Doorbar, John ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b THE FRANCIS CRICK INSTITUTE   (United Kingdom)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KITASATO UNIVERSITY   (Japan)

Author keywords

Carcinogenesis; Diversity; Evolution; Human papillomavirus; Niche; Tissue stem cells; Tropism

Indexed keywords

VIRUS PROTEIN; VIRAL PROTEIN;

CANINE ORAL PAPILLOMAVIRUS; DISEASE ASSOCIATION; EVOLUTION; GENE EXPRESSION; GENE FUNCTION; GENOME ANALYSIS; GENOTYPE; HUMAN; IMMUNE EVASION; IMMUNITY; LIFE CYCLE; NEOPLASM; NONHUMAN; PAPILLOMAVIRUS INFECTION; PATHOGENICITY; PHYLOGENY; REVIEW; STEM CELL; UTERINE CERVIX CANCER; VIRAL TROPISM; WART VIRUS; ANIMAL; CLASSIFICATION; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PAPILLOMAVIRIDAE; PHYSIOLOGY; VIROLOGY;

ALPHAPAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

ANIMALS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, VIRAL; HUMANS; NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; VIRAL PROTEINS; VIRAL TROPISM;

EID: 84937436503     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v7072802     Document Type: Review

References (141)

1. PaVE: Papillomavirus Episteme. Available online: http://pave.niaid.nih.gov/ (accessed on 11 July 2015).
2. Doorbar, J., Egawa, N., Griffin, H., Kranjec, C., Murakami, I. Human papillomavirus molecular biology and disease association. Rev. Med. Virol. 2015, 25 (Suppl. 1), 2-23. [CrossRef][PubMed]
3. Bottalico, D., Chen, Z., Dunne, A., Ostoloza, J., McKinney, S., Sun, C., Schlecht, N.F., Herrero, R., Fatahzadeh, M., Schiffman, M., et al. The oral cavity contains abundant known and novel human papillomaviruses from the betapapillomavirus and gammapapillomavirus genera. J. Infect. Dis. 2011, 204, 787-792. [CrossRef][PubMed]
4. De Koning, M.N., Quint, K.D., Bruggink, S.C., Gussekloo, J., Bouwes Bavinck, J.N., Quint, W.G., Feltkamp, M.C., Eekhof, J.A. High prevalence of cutaneous warts in elementary school children and the ubiquitous presence of wart-associated human papillomavirus on clinically normal skin. Br. J. Dermatol. 2015, 172, 196-201. [CrossRef][PubMed]
5. Poljak, M., Kocjan, B.J., Potocnik, M., Seme, K. Anogenital hairs are an important reservoir of a-papillomaviruses in patients with genital warts. J. Infect. Dis. 2009, 199, 1270-1274. [CrossRef][PubMed]
6. Potocnik, M., Kocjan, B.J., Seme, K., Luzar, B., Babic, D.Z., Poljak, M. a-papillomaviruses in anogenital hairs plucked from healthy individuals. J. Med. Virol. 2006, 78, 1673-1678. [CrossRef][PubMed]
7. De Koning, M.N., Struijk, L., Bavinck, J.N., Kleter, B., ter Schegget, J., Quint, W.G., Feltkamp, M.C. Betapapillomaviruses frequently persist in the skin of healthy individuals. J. Gen. Virol. 2007, 88, 1489-1495. [CrossRef][PubMed]
8. Antonsson, A., Erfurt, C., Hazard, K., Holmgren, V., Simon, M., Kataoka, A., Hossain, S., Hakangard, C., Hansson, B.G. Prevalence and type spectrum of human papillomaviruses in healthy skin samples collected in three continents. J. Gen. Virol. 2003, 84, 1881-1886. [CrossRef][PubMed]
9. Antonsson, A., Karanfilovska, S., Lindqvist, P.G., Hansson, B.G. General acquisition of human papillomavirus infections of skin occurs in early infancy. J. Clin. Microbiol. 2003, 41, 2509-2514. [CrossRef][PubMed]
10. Jablonska, S., Orth, G. Epidermodysplasia verruciformis. Clin. Dermatol. 1985, 3, 83-96. [CrossRef]
11. Quint, K.D., Genders, R.E., de Koning, M.N., Borgogna, C., Gariglio, M., Bouwes Bavinck, J.N., Doorbar, J., Feltkamp, M.C. Human a-papillomavirus infection and keratinocyte carcinomas. J. Pathol. 2015, 235, 342-354. [CrossRef][PubMed]
12. Goon, P., Sonnex, C., Jani, P., Stanley, M., Sudhoff, H. Recurrent respiratory papillomatosis: An overview of current thinking and treatment. Eur. Arch. Oto-Rhino-Laryngol. 2008, 265, 147-151. [CrossRef][PubMed]
13. Cubie, H.A. Diseases associated with human papillomavirus infection. Virology 2013, 445, 21-34. [CrossRef][PubMed]
14. Harwood, C.A., Spink, P.J., Surentheran, T., Leigh, I.M., de Villiers, E.M., McGregor, J.M., Proby, C.M., Breuer, J. Degenerate and nested PCR: A highly sensitive and specific method for detection of human papillomavirus infection in cutaneous warts. J. Clin. Microbiol. 1999, 37, 3545-3555. [PubMed]
15. Rogers, H.D., Macgregor, J.L., Nord, K.M., Tyring, S., Rady, P., Engler, D.E., Grossman, M.E. Acquired epidermodysplasia verruciformis. J. Am. Acad. Dermatol. 2009, 60, 315-320. [CrossRef][PubMed]
16. Bouwes Bavinck, J.N., Feltkamp, M., Struijk, L., ter Schegget, J. Human papillomavirus infection and skin cancer risk in organ transplant recipients. J. Investig. Dermatol. Symp. Proc. Soc. 2001, 6, 207-211. [CrossRef][PubMed]
17. Van Doorslaer, K. Evolution of the papillomaviridae. Virology 2013, 445, 11-20. [CrossRef][PubMed]
18. Bravo, I.G., Felez-Sanchez, M. Papillomaviruses: Viral evolution, cancer and evolutionary medicine. Evol. Med. Public Health 2015, 2015, 32-51. [CrossRef][PubMed]
19. Van Doorslaer, K., Burk, R.D. Evolution of human papillomavirus carcinogenicity. Adv. Virus Res. 2010, 77, 41-62. [PubMed]
20. Burk, R.D., Chen, Z., van Doorslaer, K. Human papillomaviruses: Genetic basis of carcinogenicity. Public Health Genomics 2009, 12, 281-290. [CrossRef][PubMed]
21. Bernard, H.U., Burk, R.D., Chen, Z., van Doorslaer, K., zur Hausen, H., de Villiers, E.M. Classification of papillomaviruses (PVS) based on 189 PV types and proposal of taxonomic amendments. Virology 2010, 401, 70-79. [CrossRef][PubMed]
22. De Villiers, E.M., Fauquet, C., Broker, T.R., Bernard, H.U., zur Hausen, H. Classification of papillomaviruses. Virology 2004, 324, 17-27. [CrossRef][PubMed]
23. Drolet, M., Benard, E., Boily, M.C., Ali, H., Baandrup, L., Bauer, H., Beddows, S., Brisson, J., Brotherton, J.M., Cummings, T., et al. Population-level impact and herd effects following human papillomavirus vaccination programmes: A systematic review and meta-analysis. Lancet. Infect. Dis. 2015, 15, 565-580. [CrossRef]
24. Buck, C.B., Day, P.M., Trus, B.L. The papillomavirus major capsid protein L1. Virology 2013, 445, 169-174. [CrossRef][PubMed]
25. Dasgupta, J., Bienkowska-Haba, M., Ortega, M.E., Patel, H.D., Bodevin, S., Spillmann, D., Bishop, B., Sapp, M., Chen, X.S. Structural basis of oligosaccharide receptor recognition by human papillomavirus. J. Biol. Chem. 2011, 286, 2617-2624. [CrossRef][PubMed]
26. Doorbar, J., Quint, W., Banks, L., Bravo, I.G., Stoler, M., Broker, T.R., Stanley, M.A. The biology and life-cycle of human papillomaviruses. Vaccine 2012, 30, F55-F70. [CrossRef][PubMed]
27. Egawa, K. New types of human papillomaviruses and intracytoplasmic inclusion bodies: A classification of inclusion warts according to clinical features, histology and associated HPV types. Br. J. Dermatol. 1994, 130, 158-166. [CrossRef][PubMed]
28. Egawa, K., Honda, Y., Inaba, Y., Ono, T. Pigmented viral warts: A clinical and histopathological study including human papillomavirus typing. Br. J. Dermatol. 1998, 138, 381-389. [CrossRef][PubMed]
29. Egawa, K., Delius, H., Matsukura, T., Kawashima, M., de Villiers, E.M. Two novel types of human papillomavirus, HPV 63 and HPV 65: Comparisons of their clinical and histological features and DNA sequences to other HPV types. Virology 1993, 194, 789-799. [CrossRef][PubMed]
30. Egawa, K., Kimmel, R., de Villiers, E.M. A novel type of human papillomavirus (HPV 95): Comparison with infections of closely related human papillomavirus types. Br. J. Dermatol. 2005, 153, 688-689. [CrossRef][PubMed]
31. Ball, S.L., Winder, D.M., Vaughan, K., Hanna, N., Levy, J., Sterling, J.C., Stanley, M.A., Goon, P.K. Analyses of human papillomavirus genotypes and viral loads in anogenital warts. J. Med. Virol. 2011, 83, 1345-1350. [CrossRef][PubMed]
32. Dickens, P., Srivastava, G., Loke, S.L., Larkin, S. Human papillomavirus 6, 11, and 16 in laryngeal papillomas. J. Pathol. 1991, 165, 243-246. [CrossRef][PubMed]
33. Syrjanen, S. Human papillomavirus infections and oral tumors. Med. Microbiol. Immunol. Berl 2003, 192, 123-128. [CrossRef][PubMed]
34. De Villiers, E.M. Human pathogenic papillomavirus types: An update. Curr. Top. Microbiol. Immunol. 1994, 186, 1-12. [PubMed]
35. Orth, G., Jablonska, S., Favre, M., Croissant, O., Obalek, S., Jarzabek-Chorzelska, M., Jibard, N. Identification of papillomaviruses in butchers’ warts. J. Investig. Dermatol. 1981, 76, 97-102. [CrossRef][PubMed]
36. International Agency for the Research on Cancer. Avilable online: http://monographs.iarc.fr/ ENG/ Monographs/vol90/ (acessed on 11 July 2015).
37. Munoz, N., Bosch, F.X., de Sanjose, S., Herrero, R., Castellsague, X., Shah, K.V., Snijders, P.J., Meijer, C.J., International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 2003, 348, 518-527. [CrossRef][PubMed]
38. Herrero, R., Castellsague, X., Pawlita, M., Lissowska, J., Kee, F., Balaram, P., Rajkumar, T., Sridhar, H., Rose, B., Pintos, J., et al. Human papillomavirus and oral cancer: The international agency for research on cancer multicenter study. J. Natl. Cancer Inst. 2003, 95, 1772-1783. [CrossRef][PubMed]
39. Day, P.M., Schelhaas, M. Concepts of papillomavirus entry into host cells. Curr. Opin. Virol. 2014, 4, 24-31. [CrossRef][PubMed]
40. Steinberg, B.M., Auborn, K.J., Brandsma, J.L., Taichman, L.B. Tissue site-specific enhancer function of the upstream regulatory region of human papillomavirus type 11 in cultured keratinocytes. J. Virol. 1989, 63, 957-960. [PubMed]
41. Ottinger, M., Smith, J.A., Schweiger, M.R., Robbins, D., Powell, M.L., You, J., Howley, P.M. Cell-type specific transcriptional activities among different papillomavirus long control regions and their regulation by E2. Virology 2009, 395, 161-171. [CrossRef][PubMed]
42. Mistry, N., Wibom, C., Evander, M. Cutaneous and mucosal human papillomaviruses differ in net surface charge, potential impact on tropism. Virol. J. 2008, 5
43. [CrossRef][PubMed]
44. Egawa, K., Inaba, Y., Yoshimura, K., Ono, T. Varied clinical morphology of HPV-1-induced warts, depending on anatomical factors. Br. J. Dermatol. 1993, 128, 271-276. [CrossRef][PubMed]
45. Trenfield, K., Spradbrow, P.B., Vanselow, B. Sequences of papillomavirus DNA in equine sarcoids. Equine Vet. J. 1985, 17, 449-452. [CrossRef][PubMed]
46. Otten, N., von Tscharner, C., Lazary, S., Antczak, D.F., Gerber, H. DNA of bovine papillomavirus type 1 and 2 in equine sarcoids: Pcr detection and direct sequencing. Arch. Virol. 1993, 132, 121-131. [CrossRef][PubMed]
47. Angelos, J.A., Marti, E., Lazary, S., Carmichael, L.E. Characterization of BPV-like DNA in equine sarcoids. Arch. Virol. 1991, 119, 95-109. [CrossRef][PubMed]
48. Chambers, G., Ellsmore, V.A., O’Brien, P.M., Reid, S.W., Love, S., Campo, M.S., Nasir, L. Association of bovine papillomavirus with the equine sarcoid. J. Gen. Virol. 2003, 84, 1055-1062. [CrossRef][PubMed]
49. Rous, P., Beard, J.W. The progression to carcinoma of virus-induced rabbit papillomas (shope). J. Exp. Med. 1935, 62, 523-548. [CrossRef][PubMed]
50. Syverton, J.T. The pathogenesis of the rabbit papilloma-to-carcinoma sequence. Ann. N. Y. Acad. Sci. 1952, 54, 1126-1140. [CrossRef][PubMed]
51. Jeckel, S., Huber, E., Stubenrauch, F., Iftner, T. A transactivator function of cottontail rabbit papillomavirus E2 is essential for tumor induction in rabbits. J. Virol. 2002, 76, 11209-11215. [CrossRef][PubMed]
52. Meyers, C., Harry, J., Lin, Y.L., Wettstein, F.O. Identification of three transforming proteins encoded by cottontail rabbit papillomavirus. J. Virol. 1992, 66, 1655-1664. [PubMed]
53. Gjoerup, O., Chang, Y. Update on human polyomaviruses and cancer. Adv. Cancer Res. 2010, 106, 1-51. [PubMed]
54. Schlesinger, R.W. Adenoviruses: The nature of the virion and of controlling factors in productive or abortive infection and tumorigenesis. Adv. Virus Res. 1969, 14, 1-61. [PubMed]
55. Pipas, J.M. SV40: Cell transformation and tumorigenesis. Virology 2009, 384, 294-303. [CrossRef][PubMed]
56. Endter, C., Dobner, T. Cell transformation by human adenoviruses. Curr. Top. Microbiol. Immunol. 2004, 273, 163-214. [PubMed]
57. Vande Pol, S.B., Klingelhutz, A.J. Papillomavirus E6 oncoproteins. Virology 2013, 445, 115-137. [CrossRef][PubMed]
58. Roman, A., Munger, K. The papillomavirus E7 proteins. Virology 2013, 445, 138-168. [CrossRef][PubMed]
59. Middleton, K., Peh, W., Southern, S., Griffin, H., Sotlar, K., Nakahara, T., El-Sherif, A., Morris, L., Seth, R., Hibma, M., et al. Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers. J. Virol. 2003, 77, 10186-10201. [CrossRef][PubMed]
60. Griffin, H., Soneji, Y., van Baars, R., Arora, R., Jenkins, D., van de Sandt, M., Wu, Z., Quint, W., Jach, R., Okon, K., et al. Stratification of HPV-induced cervical pathology using the virally encoded molecular marker E4 in conbination with p16 or mcm. Mod. Pathol. 2015. [CrossRef][PubMed]
61. Khare, S., Pater, M.M., Tang, S.C., Pater, A. Effect of glucocorticoid hormones on viral gene expression, growth, and dysplastic differentiation in HPV16-immortalized ectocervical cells. Exp. Cell Res. 1997, 232, 353-360. [CrossRef][PubMed]
62. Mittal, R., Tsutsumi, K., Pater, A., Pater, M.M. Human papillomavirus type 16 expression in cervical keratinocytes: Role of progesterone and glucocorticoid hormones. Obstet. Gynecol. 1993, 81, 5-12. [PubMed]
63. Kyo, S., Inoue, M., Hayasaka, N., Inoue, T., Yutsudo, M., Tanizawa, O., Hakura, A. Regulation of early gene expression of human papillomavirus type 16 by inflammatory cytokines. Virology 1994, 200, 130-139. [CrossRef][PubMed]
64. Antonsson, A., Forslund, O., Ekberg, H., Sterner, G., Hansson, B.G. The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J. Virol. 2000, 74, 11636-11641. [CrossRef][PubMed]
65. Antonsson, A., Hansson, B.G. Healthy skin of many animal species harbors papillomaviruses which are closely related to their human counterparts. J. Virol. 2002, 76, 12537-12542. [CrossRef][PubMed]
66. Maglennon, G.A., McIntosh, P., Doorbar, J. Persistence of viral DNA in the epithelial basal layer suggests a model for papillomavirus latency following immune regression. Virology 2011, 414, 153-163. [CrossRef][PubMed]
67. Maglennon, G.A., McIntosh, P.B., Doorbar, J. Immunosuppression facilitates the reactivation of latent papillomavirus infections. J. Virol. 2014, 88, 710-716. [CrossRef][PubMed]
68. Doorbar, J. Latent papillomavirus infections and their regulation. Curr. Opin. Virol. 2013, 3, 416-421. [CrossRef][PubMed]
69. Gravitt, P.E. Evidence and impact of human papillomavirus latency. Open Virol. J. 2012, 6, 198-203. [CrossRef][PubMed]
70. De Villiers, E.M. Cross-roads in the classification of papillomaviruses. Virology 2013, 445, 2-10. [CrossRef][PubMed]
71. Delius, H., van Ranst, M.A., Jenson, A.B., zur Hausen, H., Sundberg, J.P. Canine oral papillomavirus genomic sequence: A unique 1.5-kb intervening sequence between the E2 and L2 open reading frames. Virology 1994, 204, 447-452. [CrossRef][PubMed]
72. Terai, M., Burk, R.D. Felis domesticus papillomavirus, isolated from a skin lesion, is related to canine oral papillomavirus and contains a 1.3 kb non-coding region between the E2 and L2 open reading frames. J. Gen. Virol. 2002, 83, 2303-2307. [PubMed]
73. Bergvall, M., Melendy, T., Archambault, J. The E1 proteins. Virology 2013, 445, 35-56. [CrossRef][PubMed]
74. McBride, A.A. The papillomavirus E2 proteins. Virology 2013, 445, 57-79. [CrossRef][PubMed]
75. Wang, J.W., Roden, R.B. L2, the minor capsid protein of papillomavirus. Virology 2013, 445, 175-186. [CrossRef][PubMed]
76. DiMaio, D., Petti, L.M. The E5 proteins. Virology 2013, 445, 99-114. [CrossRef][PubMed]
77. Doorbar, J. The E4 protein; structure, function and patterns of expression. Virology 2013, 445, 80-98. [CrossRef][PubMed]
78. Chen, X.S., Garcea, R.L., Goldberg, I., Casini, G., Harrison, S.C. Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. Mol. Cell 2000, 5, 557-567. [CrossRef]
79. Holmgren, S.C., Patterson, N.A., Ozbun, M.A., Lambert, P.F. The minor capsid protein L2 contributes to two steps in the human papillomavirus type 31 life cycle. J. Virol. 2005, 79, 3938-3948. [CrossRef][PubMed]
80. Doorbar, J. The papillomavirus life cycle. J. Clin. Virol. 2005, 32, S7-S15. [CrossRef][PubMed]
81. Kines, R.C., Thompson, C.D., Lowy, D.R., Schiller, J.T., Day, P.M. The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding. Proc. Natl. Acad. Sci. USA 2009, 106, 20458-20463. [CrossRef][PubMed]
82. Pyeon, D., Pearce, S.M., Lank, S.M., Ahlquist, P., Lambert, P.F. Establishment of human papillomavirus infection requires cell cycle progression. PLoS Pathog. 2009, 5, e1000318. [CrossRef][PubMed]
83. Parish, J.L., Bean, A.M., Park, R.B., Androphy, E.J. Chlr1 is required for loading papillomavirus E2 onto mitotic chromosomes and viral genome maintenance. Mol. Cell 2006, 24, 867-876. [CrossRef][PubMed]
84. Doorbar, J. Molecular biology of human papillomavirus infection and cervical cancer. Clin. Sci. Lond. 2006, 110, 525-541. [CrossRef][PubMed]
85. Melendy, T., Sedman, J., Stenlund, A. Cellular factors required for papillomavirus DNA replication. J. Virol. 1995, 69, 7857-7867. [PubMed]
86. White, E.A., Howley, P.M. Proteomic approaches to the study of papillomavirus-host interactions. Virology 2013, 435, 57-69. [CrossRef][PubMed]
87. Yu, J.H., Lin, B.Y., Deng, W., Broker, T.R., Chow, L.T. Mitogen-activated protein kinases activate the nuclear localization sequence of human papillomavirus type 11 E1 DNA helicase to promote efficient nuclear import. J. Virol. 2007, 81, 5066-5078. [CrossRef][PubMed]
88. Fradet-Turcotte, A., Moody, C., Laimins, L.A., Archambault, J. Nuclear export of human papillomavirus type 31 E1 is regulated by CDK2 phosphorylation and required for viral genome maintenance. J. Virol. 2010, 84, 11747-11760. [CrossRef][PubMed]
89. McIntosh, P.B., Laskey, P., Sullivan, K., Davy, C., Wang, Q., Jackson, D.J., Griffin, H.M., Doorbar, J. E1-E4-mediated keratin phosphorylation and ubiquitylation: A mechanism for keratin depletion in HPV16-infected epithelium. J. Cell Sci. 2010, 123, 2810-2822. [CrossRef][PubMed]
90. McIntosh, P.B., Martin, S.R., Jackson, D.J., Khan, J., Isaacson, E.R., Calder, L., Raj, K., Griffin, H.M., Wang, Q., Laskey, P., et al. Structural analysis reveals an amyloid form of the human papillomavirus type 16 E1-E4 protein and provides a molecular basis for its accumulation. J. Virol. 2008, 82, 8196-8203. [CrossRef][PubMed]
91. Nicholls, P., Klaunberg, B., Moore, R.A., Santos, E.B., Parry, N.R., Gough, G.W., Stanley, M.A. Naturally occurring, nonregressing canine oral papillomavirus infection: Host immunity, virus characterization, and experimental infection. Virology 1999, 265, 365-374. [CrossRef][PubMed]
92. Wilgenburg, B.J., Budgeon, L.R., Lang, C.M., Griffith, J.W., Christensen, N.D. Characterization of immune responses during regression of rabbit oral papillomavirus infections. Comp. Med. 2005, 55, 431-439. [PubMed]
93. Nicholls, P.K., Moore, P.F., Anderson, D.M., Moore, R.A., Parry, N.R., Gough, G.W., Stanley, M.A. Regression of canine oral papillomas is associated with infiltration of CD4+ and CD8+ lymphocytes. Virology 2001, 283, 31-39. [CrossRef][PubMed]
94. Coleman, N., Birley, H.D., Renton, A.M., Hanna, N.F., Ryait, B.K., Byrne, M., Taylor-Robinson, D., Stanley, M.A. Immunological events in regressing genital warts. Am. J. Clin. Pathol. 1994, 102, 768-774. [PubMed]
95. Monnier-Benoit, S., Mauny, F., Riethmuller, D., Guerrini, J.S., Capilna, M., Felix, S., Seilles, E., Mougin, C., Pretet, J.L. Immunohistochemical analysis of CD4+ and CD8+ T-cell subsets in high risk human papillomavirus-associated pre-malignant and malignant lesions of the uterine cervix. Gynecol. Oncol. 2006, 102, 22-31. [CrossRef][PubMed]
96. Stanley, M.A. Epithelial cell responses to infection with human papillomavirus. Clin. Microbiol. Rev. 2012, 25, 215-222. [CrossRef][PubMed]
97. Kanodia, S., Fahey, L.M., Kast, W.M. Mechanisms used by human papillomaviruses to escape the host immune response. Curr. Cancer Drug Targets 2007, 7, 79-89. [CrossRef][PubMed]
98. Egawa, K. Do human papillomaviruses target epidermal stem cells? Dermatology 2003, 207, 251-254. [CrossRef][PubMed]
99. Herfs, M., Vargas, S.O., Yamamoto, Y., Howitt, B.E., Nucci, M.R., Hornick, J.L., McKeon, F.D., Xian, W., Crum, C.P. A novel blueprint for “top down” differentiation defines the cervical squamocolumnar junction during development, reproductive life, and neoplasia. J. Pathol. 2013, 229, 460-468. [CrossRef][PubMed]
100. Herfs, M., Yamamoto, Y., Laury, A., Wang, X., Nucci, M.R., McLaughlin-Drubin, M.E., Munger, K., Feldman, S., McKeon, F.D., Xian, W., et al. A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer. Proc. Natl. Acad. Sci. USA 2012, 109, 10516-10521. [CrossRef][PubMed]
101. Watt, F.M. Epidermal stem cells: Markers, patterning and the control of stem cell fate. Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci. 1998, 353, 831-837. [CrossRef][PubMed]
102. Potten, C.S. Cell replacement in epidermis (keratopoiesis) via discrete units of proliferation. Int. Rev. Cytol. 1981, 69, 271-318. [PubMed]
103. Feuerman, E. Verruca vulgaris—Benign tumor of viral etiology and clonal development. Harefuah 1972, 83, 211-212. [PubMed]
104. Schmitt, A., Rochat, A., Zeltner, R., Borenstein, L., Barrandon, Y., Wettstein, F.O., Iftner, T. The primary target cells of the high-risk cottontail rabbit papillomavirus colocalize with hair follicle stem cells. J. Virol. 1996, 70, 1912-1922. [PubMed]
105. Martens, J.E., Smedts, F.M., Ploeger, D., Helmerhorst, T.J., Ramaekers, F.C., Arends, J.W., Hopman, A.H. Distribution pattern and marker profile show two subpopulations of reserve cells in the endocervical canal. Int. J. Gynecol. Pathol. 2009, 28, 381-388. [CrossRef][PubMed]
106. Mirkovic, J., Howitt, B.E., Roncarati, P., Demoulin, S., Suarez-Carmona, M., Hubert, P., McKeon, F.D., Xian, W., Li, A., Delvenne, P., et al. Carcinogenic HPV infection in the cervical squamo-columnar junction. J. Pathol. 2015, 236, 265-271. [CrossRef][PubMed]
107. Isaacson Wechsler, E., Wang, Q., Roberts, I., Pagliarulo, E., Jackson, D., Untersperger, C., Coleman, N., Griffin, H., Doorbar, J. Reconstruction of human papillomavirus type 16-mediated early-stage neoplasia implicates E6/E7 deregulation and the loss of contact inhibition in neoplastic progression. J. Virol. 2012, 86, 6358-6364. [CrossRef][PubMed]
108. Cotsarelis, G., Sun, T.T., Lavker, R.M. Label-retaining cells reside in the bulge area of pilosebaceous unit: Implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell 1990, 61, 1329-1337. [CrossRef]
109. Cotsarelis, G. Epithelial stem cells: A folliculocentric view. J. Investig. Dermatol. 2006, 126, 1459-1468. [CrossRef][PubMed]
110. Ghazizadeh, S., Taichman, L.B. Organization of stem cells and their progeny in human epidermis. J. Investig. Dermatol. 2005, 124, 367-372. [CrossRef][PubMed]
111. Taylor, G., Lehrer, M.S., Jensen, P.J., Sun, T.T., Lavker, R.M. Involvement of follicular stem cells in forming not only the follicle but also the epidermis. Cell 2000, 102, 451-461. [CrossRef]
112. Ito, M., Liu, Y., Yang, Z., Nguyen, J., Liang, F., Morris, R.J., Cotsarelis, G. Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis. Nat. Med. 2005, 11, 1351-1354. [CrossRef][PubMed]
113. Kaur, P. Interfollicular epidermal stem cells: Identification, challenges, potential. J. Investig. Dermatol. 2006, 126, 1450-1458. [CrossRef][PubMed]
114. Braun, K.M., Niemann, C., Jensen, U.B., Sundberg, J.P., Silva-Vargas, V., Watt, F.M. Manipulation of stem cell proliferation and lineage commitment: Visualisation of label-retaining cells in wholemounts of mouse epidermis. Development 2003, 130, 5241-5255. [CrossRef][PubMed]
115. Lavker, R.M., Sun, T.T. Epidermal stem cells. J. Investig. Dermatol. 1983, 81, 121s-127s. [CrossRef][PubMed]
116. Ghazizadeh, S., Taichman, L.B. Multiple classes of stem cells in cutaneous epithelium: A lineage analysis of adult mouse skin. EMBO J. 2001, 20, 1215-1222. [CrossRef][PubMed]
117. Miller, S.J., Burke, E.M., Rader, M.D., Coulombe, P.A., Lavker, R.M. Re-epithelialization of porcine skin by the sweat apparatus. J. Investig. Dermatol. 1998, 110, 13-19. [CrossRef][PubMed]
118. Lu, C.P., Polak, L., Rocha, A.S., Pasolli, H.A., Chen, S.C., Sharma, N., Blanpain, C., Fuchs, E. Identification of stem cell populations in sweat glands and ducts reveals roles in homeostasis and wound repair. Cell 2012, 150, 136-150. [CrossRef][PubMed]
119. Jablonska, S., Dabrowski, J., Jakubowicz, K. Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. Cancer Res. 1972, 32, 583-589. [PubMed]
120. Orth, G. Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses. Semin. Immunol. 2006, 18, 362-374. [CrossRef][PubMed]
121. Lazarczyk, M., Dalard, C., Hayder, M., Dupre, L., Pignolet, B., Majewski, S., Vuillier, F., Favre, M., Liblau, R.S. Ever proteins, key elements of the natural anti-human papillomavirus barrier, are regulated upon t-cell activation. PLoS ONE 2012, 7, e39995. [CrossRef][PubMed]
122. Boxman, I.L., Berkhout, R.J., Mulder, L.H., Wolkers, M.C., Bouwes Bavinck, J.N., Vermeer, B.J., Schegget, J. Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J. Investig. Dermatol. 1997, 108, 712-715. [CrossRef][PubMed]
123. Boxman, I.L., Mulder, L.H., Russell, A., Bouwes Bavinck, J.N., Green, A., Ter Schegget, J. Human papillomavirus type 5 is commonly present in immunosuppressed and immunocompetent individuals. Br. J. Dermatol. 1999, 141, 246-249. [CrossRef][PubMed]
124. Jablonska, S., Orth, G., Obalek, S., Croissant, O. Cutaneous warts. Clinical, histologic, and virologic correlations. Clin. Dermatol. 1985, 3, 71-82. [CrossRef]
125. Egawa, K. Eccrine-centred distribution of human papillomavirus 63 infection in the epidermis of the plantar skin. Br. J. Dermatol. 2005, 152, 993-996. [CrossRef][PubMed]
126. Boxman, I.L., Hogewoning, A., Mulder, L.H., Bouwes Bavinck, J.N., ter Schegget, J. Detection of human papillomavirus types 6 and 11 in pubic and perianal hair from patients with genital warts. J. Clin. Microbiol. 1999, 37, 2270-2273. [PubMed]
127. Kocjan, B.J., Poljak, M., Seme, K., Potocnik, M., Fujs, K., Babic, D.Z. Distribution of human papillomavirus genotypes in plucked eyebrow hairs from slovenian males with genital warts. Infect. Genet. Evol. J. Mol. Epidemiol. Evol. Genet. Infect. Dis. 2005, 5, 255-259. [CrossRef][PubMed]
128. Javier, R.T. Cell polarity proteins: Common targets for tumorigenic human viruses. Oncogene 2008, 27, 7031-7046. [CrossRef][PubMed]
129. Kranjec, C., Banks, L. A systematic analysis of human papillomavirus (HPV) E6 pdz substrates identifies magi-1 as a major target of HPV type 16 (HPV-16) and HPV-18 whose loss accompanies disruption of tight junctions. J. Virol. 2011, 85, 1757-1764. [CrossRef][PubMed]
130. Massimi, P., Narayan, N., Thomas, M., Gammoh, N., Strand, S., Strand, D., Banks, L. Regulation of the hdlg/hscrib/hugl-1 tumour suppressor complex. Exp. Cell Res. 2008, 314, 3306-3317. [CrossRef][PubMed]
131. Pim, D., Bergant, M., Boon, S.S., Ganti, K., Kranjec, C., Massimi, P., Subbaiah, V.K., Thomas, M., Tomaic, V., Banks, L. Human papillomaviruses and the specificity of pdz domain targeting. FEBS J. 2012, 279, 3530-3537. [CrossRef][PubMed]
132. Thomas, M., Dasgupta, J., Zhang, Y., Chen, X., Banks, L. Analysis of specificity determinants in the interactions of different HPV E6 proteins with their pdz domain-containing substrates. Virology 2008, 376, 371-378. [CrossRef][PubMed]
133. Fu, L., van Doorslaer, K., Chen, Z., Ristriani, T., Masson, M., Trave, G., Burk, R.D. Degradation of p53 by human alphapapillomavirus E6 proteins shows a stronger correlation with phylogeny than oncogenicity. PLoS ONE 2010, 5, e12816. [CrossRef][PubMed]
134. Zanier, K., M’hamed Sidi, A., Boulade-Ladame, C., Rybin, V., Chappelle, A., Atkinson, A., Kieffer, B., Trave, G. Solution structure analysis of the HPV16 E6 oncoprotein reveals a self-association mechanism required for E6-mediated degradation of p53. Structure 2012, 20, 604-617. [CrossRef][PubMed]
135. Pim, D., Banks, L. Interaction of viral oncoproteins with cellular target molecules: Infection with high-risk vs. low-risk human papillomaviruses. Apmis 2010, 118, 471-493. [CrossRef][PubMed]
136. Zheng, Z.M., Baker, C.C. Papillomavirus genome structure, expression, and post-transcriptional regulation. Front. Biosci. 2006, 11, 2286-2302. [CrossRef][PubMed]
137. Westra, W.H. The morphologic profile of HPV-related head and neck squamous carcinoma: Implications for diagnosis, prognosis, and clinical management. Head Neck Pathol. 2012, 6, S48-S54. [CrossRef][PubMed]
138. Parkin, D.M. The global health burden of infection-associated cancers in the year 2002. Int. J. Cancer J. Int. Cancer 2006, 118, 3030-3044. [CrossRef][PubMed]
139. Munoz, N., Bosch, F.X., Castellsague, X., Diaz, M., de Sanjose, S., Hammouda, D., Shah, K.V., Meijer, C.J. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int. J. Cancer J. Int. Cancer 2004, 111, 278-285. [CrossRef][PubMed]
140. Gross, G., Hagedorn, M., Ikenberg, H., Rufli, T., Dahlet, C., Grosshans, E., Gissmann, L. Bowenoid papulosis. Presence of human papillomavirus (HPV) structural antigens and of HPV 16-related DNA sequences. Arch. Dermatol. 1985, 121, 858-863. [CrossRef][PubMed]
141. Tschandl, P., Rosendahl, C., Kittler, H. Cutaneous human papillomavirus infection: Manifestations and diagnosis. Curr. Probl. Dermatol. 2014, 45, 92-97. [PubMed]